McKesson Co. (NYSE:MCK) CFO Britt J. Vitalone Sells 22,085 Shares

McKesson Co. (NYSE:MCK) CFO Britt J. Vitalone sold 22,085 shares of the company’s stock in a transaction that occurred on Monday, September 13th. The shares were sold at an average price of $203.75, for a total value of $4,499,818.75. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website.

NYSE MCK traded up $2.74 on Wednesday, reaching $206.73. The stock had a trading volume of 13,624 shares, compared to its average volume of 1,073,468. The company has a debt-to-equity ratio of 82.70, a quick ratio of 0.53 and a current ratio of 0.99. McKesson Co. has a 12-month low of $141.32 and a 12-month high of $210.00. The business’s 50-day moving average price is $199.56 and its 200 day moving average price is $194.07. The stock has a market cap of $31.98 billion, a P/E ratio of -7.29, a price-to-earnings-growth ratio of 1.33 and a beta of 0.88.

McKesson (NYSE:MCK) last issued its quarterly earnings results on Wednesday, August 4th. The company reported $5.56 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $4.09 by $1.47. The firm had revenue of $62.67 billion during the quarter, compared to the consensus estimate of $60.16 billion. McKesson had a positive return on equity of 216.39% and a negative net margin of 1.83%. The company’s revenue for the quarter was up 12.6% on a year-over-year basis. During the same period last year, the company earned $2.77 earnings per share. On average, sell-side analysts predict that McKesson Co. will post 20.27 earnings per share for the current year.

The company also recently declared a quarterly dividend, which will be paid on Friday, October 1st. Investors of record on Wednesday, September 1st will be issued a dividend of $0.47 per share. This is a boost from McKesson’s previous quarterly dividend of $0.42. This represents a $1.88 annualized dividend and a yield of 0.91%. The ex-dividend date is Tuesday, August 31st. McKesson’s dividend payout ratio is currently 10.92%.

Institutional investors and hedge funds have recently made changes to their positions in the business. Y Intercept Hong Kong Ltd lifted its holdings in shares of McKesson by 539.2% in the 1st quarter. Y Intercept Hong Kong Ltd now owns 11,301 shares of the company’s stock valued at $2,221,000 after buying an additional 9,533 shares during the period. Arrowstreet Capital Limited Partnership lifted its holdings in McKesson by 74.2% in the first quarter. Arrowstreet Capital Limited Partnership now owns 734,812 shares of the company’s stock valued at $143,318,000 after acquiring an additional 313,020 shares during the period. Advisor Group Holdings Inc. boosted its position in shares of McKesson by 4.3% during the 2nd quarter. Advisor Group Holdings Inc. now owns 32,584 shares of the company’s stock worth $6,239,000 after purchasing an additional 1,332 shares in the last quarter. Penserra Capital Management LLC grew its stake in shares of McKesson by 18.6% during the 1st quarter. Penserra Capital Management LLC now owns 408 shares of the company’s stock worth $79,000 after purchasing an additional 64 shares during the period. Finally, Todd Asset Management LLC increased its holdings in shares of McKesson by 6.1% in the 2nd quarter. Todd Asset Management LLC now owns 104,367 shares of the company’s stock valued at $19,959,000 after purchasing an additional 5,958 shares in the last quarter. 86.16% of the stock is currently owned by institutional investors.

MCK has been the subject of a number of research analyst reports. Credit Suisse Group upped their price target on McKesson from $222.00 to $224.00 and gave the company a “neutral” rating in a report on Monday, August 9th. Deutsche Bank Aktiengesellschaft upped their price target on McKesson from $237.00 to $261.00 and gave the company a “buy” rating in a report on Thursday, August 5th. Two research analysts have rated the stock with a hold rating and six have issued a buy rating to the company. According to MarketBeat.com, the stock currently has an average rating of “Buy” and an average price target of $224.13.

About McKesson

McKesson Corp. engages in the provision of supply chain management solutions, retail pharmacy, community oncology and specialty care, and healthcare information technology. It operates through the following segments: U.S. Pharmaceutical; International; Medical-Surgical Solutions; and Prescription Technology Solutions (“RxTS“).

Recommended Story: Cash Asset Ratio

Insider Buying and Selling by Quarter for McKesson (NYSE:MCK)

Receive News & Ratings for McKesson Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for McKesson and related companies with MarketBeat.com's FREE daily email newsletter.